S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Mylan To Acquire Abbott's Non-U.S. Developed Markets Specialty And Branded Generics Business In An All-Stock Transaction|
|Mylan Wins Motion to Enjoin GlaxoSmithKline from Providing Paroxetine CR to Apotex; Apotex Can No Longer Supply Authorized Generic Product|
|Mylan Launches Generic Micardis® Tablets|
|Mylan Wins Motion for Temporary Restraining Order Against Apotex for Authorized Generic of Paxil® CR|
|Mylan to Acquire U.S. Rights to Arixtra® (fondaparinux sodium) Injection from Aspen|
|Mylan Schedules Second Quarter 2014 Financial Results Conference Call and Live Webcast for Aug. 7, 2014|
|Mylan Launches Generic Precedex™ Injection - Another Key Product Approval|
|Court Grants Summary Judgment in Favor of Mylan and FDA Related to Generic Precedex™|
|Abbott to Sell its Developed Markets Branded Generics Pharmaceuticals Business to Mylan|
|Abbott Labs to sell part of generics business for $5.3 billion|
Click above to view more mutual fund data and stats for myl - Mylan Inc.